About Winterlight Labs
Winterlight Labs offers a language-based diagnostic system designed to detect cognitive diseases. The company's system uses machine learning and artificial intelligence technologies to analyze and quantify aspects of speech and language for tracking cognition and disease progression. With this technology, the company detects and monitors cognitive and mental diseases such as dementia and Alzheimer's. It was founded in 2015 and is based in Toronto, Canada. In January 2023, Winterlight Labs was acquired by Cambridge Cognition.5M.
Research containing Winterlight Labs
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Winterlight Labs in 5 CB Insights research briefs, most recently on Dec 9, 2022.
Expert Collections containing Winterlight Labs
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Winterlight Labs is included in 3 Expert Collections, including Digital Health 150.
Digital Health 150
The winners of the second annual CB Insights Digital Health 150.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
Winterlight Labs Patents
Winterlight Labs has filed 5 patents.
Kinship and descent, Family, Generalized functions, Nationality law, IBM transistorized computers
Kinship and descent, Family, Generalized functions, Nationality law, IBM transistorized computers
Latest Winterlight Labs News
Jun 27, 2023
News Provided By Share This Article Emotional Artificial Intelligence Market Stay up to date with Emotional Artificial Intelligence Market research by HTF MI. Check how key trends and emerging drivers are shaping this industry growth. HTF MI integrates History, Trends, and Forecasts to identify the highest value opportunities, cope with the most critical business challenges and transform the businesses.” — Criag Francis PUNE, MAHARASHTRA, INDIA, June 27, 2023/ EINPresswire.com / -- The Global Emotional Artificial Intelligence Market was valued at USD 33.76 Billion in 2023 and is expected to reach USD 52.4 Billion by 2029, growing at a CAGR of 21.2% during 2023-2029. The Latest research study released by HTF MI “Global Emotional Artificial Intelligence Market with 120+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know-how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint, and status. Understanding the segments helps in identifying the importance of different factors that aid market growth. Some of the Major Companies covered in this Research are Affectiva (United States), Realeyes (United Kingdom), Emotient (United States), Beyond Verbal (Israel), Sentiance (Belgium), Cogito (United States), Emoshape (United States), NuraLogix (Canada), CrowdEmotion (United Kingdom), Emotiv (United States), iMotions (Denmark), Sension (Germany), WinterLight Labs (Canada), Eyeris (United States), etc. Click here for sample + related graphs of the report @: https://www.htfmarketintelligence.com/sample-report/global-emotional-artificial-intelligence-market Browse market information, tables, and figures extent in-depth TOC on Emotional Artificial Intelligence Market by Application (Healthcare, Media & Advertisement, Automotive, Education, Gaming, Retail, Military & Defense, Others), by Product Type (Facial Expression Recognition, Speech Analysis, Gesture Recognition, Biosensors), Business scope, Manufacturing, and Outlook – Estimate to 2029. for more information or any query mail at email@example.com Finally, all parts of the Global Emotional Artificial Intelligence market are also quantitatively evaluated in order to think about the global market alike. This market study contains fundamental data and true figures about the market, which contains a deep analysis of this market based on market trends, market drivers, restrictions, and future prospects. The report delivers the global money request with the help of Porters' five forces and SWOT analysis. If you have any Enquiry please click here: https://www.htfmarketintelligence.com/enquiry-before-buy/global-emotional-artificial-intelligence-market On the basis of the report- titled segments and sub-segment of the market are highlighted below: Global Emotional Artificial Intelligence Market By Application/End-User (Value and Volume from 2023E to 2029: Healthcare, Media & Advertisement, Automotive, Education, Gaming, Retail, Military & Defense, Others Emotional Artificial Intelligence Market By Type (Value and Volume from 2023 to 2029): Facial Expression Recognition, Speech Analysis, Gesture Recognition, Biosensors Global Emotional Artificial Intelligence Market by Key Players: Affectiva (United States), Realeyes (United Kingdom), Emotient (United States), Beyond Verbal (Israel), Sentiance (Belgium), Cogito (United States), Emoshape (United States), NuraLogix (Canada), CrowdEmotion (United Kingdom), Emotiv (United States), iMotions (Denmark), Sension (Germany), WinterLight Labs (Canada), Eyeris (United States) On the basis of the report- titled segments and sub-segment of the market are highlighted below: Global Emotional Artificial Intelligence Market Study Global Emotional Artificial Intelligence Market Breakdown by Application (Healthcare, Media & Advertisement, Automotive, Education, Gaming, Retail, Military & Defense, Others) by Type (Facial Expression Recognition, Speech Analysis, Gesture Recognition, Biosensors) and by Geography (North America, South America, Europe, Asia Pacific, MEA) Market Drivers: • Emotion AI aims to improve user experience by enabling machines to understand and respond appropriately to human emotions, leading to more engaging and satisfying interactions. • Emotion AI can help businesses better understand customer sentiment, preferences, and needs, enabling them to provide personalized and targeted services, leading to improved customer satisfaction and loyalty. Market Trend: • Emotion AI is increasingly being integrated into virtual assistants and chatbots to enhance their understanding of human emotions and improve their responses and interactions. • Advancements in computer vision technologies have led to improved facial expression recognition, enabling machines to analyze and interpret emotions based on facial cues. Opportunities: • Emotion AI can be applied in healthcare settings to assist in mental health diagnosis, emotional support for patients, and remote monitoring of emotional well-being. • Emotion AI can enhance educational experiences by adapting instructional content, providing personalized feedback, and monitoring student engagement and emotional states. Challenges: • Ensuring ethical use of emotional data, privacy protection, and avoiding potential biases in emotion detection algorithms are important challenges in the development and deployment of emotional AI systems. • Developing accurate and reliable emotion recognition algorithms across diverse cultural and individual contexts is a significant challenge, as emotions can be subjective and context-dependent. Customization of the Report: The report can be customized as per your needs for added data from up to 3 businesses or countries. Global Emotional Artificial Intelligence Market by Key Players: Affectiva (United States), Realeyes (United Kingdom), Emotient (United States), Beyond Verbal (Israel), Sentiance (Belgium), Cogito (United States), Emoshape (United States), NuraLogix (Canada), CrowdEmotion (United Kingdom), Emotiv (United States), iMotions (Denmark), Sension (Germany), WinterLight Labs (Canada), Eyeris (United States) Geographically, this report is segmented into some key Regions, with manufacture, depletion, revenue (million USD), and market share and growth rate of Emotional Artificial Intelligence in these regions, from 2018 to 2028 (forecast), covering China, USA, Europe, Japan, Korea, India, Southeast Asia & South America and its Share (%) and CAGR for the forecasted period 2023 to 2028 Some of the important questions for stakeholders and business professionals for expanding their position in the Global Emotional Artificial Intelligence Market: Q 1. Which Region offers the most rewarding open doors for the market Ahead of 2022? Q 2. What are the business threats and Impacts of the latest scenario over the market Growth and Estimation? Q 3. What are probably the most encouraging, high-development scenarios for the Emotional Artificial Intelligence movement showcased by applications, types, and regions? Q 4. What segments grab the most noteworthy attention in Emotional Artificial Intelligence Market in 2020 and beyond? Q 5. Who are the significant players confronting and developing in the Emotional Artificial Intelligence Market? For More Information Read the Table of Content: https://www.htfmarketintelligence.com/report/global-emotional-artificial-intelligence-market Key poles of the TOC: Chapter 1 Global Emotional Artificial Intelligence Market Business Overview Chapter 2 Major Breakdown by Type [Facial Expression Recognition, Speech Analysis, Gesture Recognition, Biosensors] Chapter 3 Major Application Wise Breakdown (Revenue & Volume) Chapter 4 Manufacture Market Breakdown Chapter 5 Sales & Estimates Market Study Chapter 6 Key Manufacturers Production and Sales Market Comparison Breakdown ........... Chapter 9 Key Companies Breakdown by Overall Market Size & Revenue by Type Chapter 10 Business / Industry Chain (Value & Supply Chain Analysis) Chapter 11 Conclusions & Appendix Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like APAC, North America, LATAM, Europe, or Southeast Asia. Criag Francis
Winterlight Labs Frequently Asked Questions (FAQ)
When was Winterlight Labs founded?
Winterlight Labs was founded in 2015.
Where is Winterlight Labs's headquarters?
Winterlight Labs's headquarters is located at 46 Hayden St, Toronto.
What is Winterlight Labs's latest funding round?
Winterlight Labs's latest funding round is Acquired.
How much did Winterlight Labs raise?
Winterlight Labs raised a total of $4.74M.
Who are the investors of Winterlight Labs?
Investors of Winterlight Labs include Cambridge Cognition, DCTx Innovation Incubator, Hikma Ventures, First Star Ventures, Grey Sky Venture Partners and 7 more.
Who are Winterlight Labs's competitors?
Competitors of Winterlight Labs include Canary Speech, Neurotrack, Aural Analytics, Modality.AI, Kintsugi, Ellipsis Health, DiamiR, Cognoptix, NeuroLex Laboratories, Darmiyan and 16 more.
Compare Winterlight Labs to Competitors
Canary Speech develops voice technology for early illness detection with machine learning in healthcare. It offers a platform known as Voice Biomarkers to monitor and detect respiratory conditions, anxiety and stress, dementia, and more. The company was founded in 2017 and is based in Provo, Utah.
Cytox is developing a diagnostic test and therapeutic cures for Alzheimer's Disease. The company is a university spin-out based on academic research into the role of the cell cycle in neuro-degenerative diseases.
Cognoptix is a privately held medical technology company headquartered in Acton, Mass., focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer's Disease (AD).
Darmiyan develops neuroscience-powered artificial intelligence and brain imaging software. It produces maps that detect Alzheimer's disease. The company technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders with specific quantification and localization of microscopic abnormality in the brain. It was founded in 2016 and is based in Berkeley, California.
ADM Diagnostics, dba ADMdx, specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. The company provides pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. The company is developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.
Cymedix develops assays for the early detection of mitochondrial diseases such as Alzheimer's disease. Earlier detection enables earlier therapy, and development of personalized medicine solutions.